Neurology

Your Article Summary

See Latest Articles

Changes in Vitamin E Prescribing for Alzheimer Patients
American Journal of Geriatric Psychiatry, 06/24/09

Dysken MW et al. - AAGP members significantly reduced prescribing Vitamin E to patients with Alzheimer disease after 2005. The two reports are discussed with an emphasis on their methodological limitations and the potential for additional information on Vitamin E side effects from ongoing research.

• A three-item questionnaire was mailed to all AAGP members who had prescription privileges to assess changes in prescribing Vitamin E after January, 2005.

• A total of 572 completed surveys were returned for a response rate of 35%.
• Nearly 60% of respondents reported a change over the 2 years that followed the 2005 reports.
• The greatest change was in the group not prescribing Vitamin E, which increased from 6.6% before 2005 to 60.6% afterward.

Today in Neuropsych Sciences...keeping you current

Receive free subspecialty "5-minute updates" via email

A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia
Journal of Psychopharmacology, 10/19/09

Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism
Journal of Psychopharmacology, 10/20/09

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
Clinical Interventions in Aging, 09/29/09

See All of Neuropsych Sciences